Search research articles
Contact Us
Filters
Showing results (181-190 of 351) with videos related to
Page
of 36
Sort By:
Clinical and Experimental Rheumatology
|
November 13, 2018
Body mass index and persistence of conventional DMARDs and TNF inhibitors in rheumatoid arthritis
Caroline B McCulley, Jennifer L Barton, Grant W Cannon, et al.
Arthritis Care & Research
|
August 18, 2019
Performance of Administrative Algorithms to Identify Interstitial Lung Disease in Rheumatoid Arthritis
Bryant R England, Punyasha Roul, Tina D Mahajan, et al.
Frontiers in Immunology
|
September 1, 2023
Citrullinated and malondialdehyde-acetaldehyde modified fibrinogen activates macrophages and promotes an aggressive synovial fibroblast phenotype in patients with rheumatoid arthritis
Nozima Aripova, Michael J Duryee, Bryant R England, et al.
Annals of the Rheumatic Diseases
|
December 15, 2015
Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis
Anja Schwenzer, Xia Jiang, Ted R Mikuls, et al.
Frontiers in Immunology
|
April 9, 2020
Heightened Levels of Antimicrobial Response Factors in Patients With Rheumatoid Arthritis
Prathapan Ayyappan, Robert Z Harms, Jennifer A Seifert, et al.
Arthritis and Rheumatism
|
February 3, 2007
Validity of gout diagnoses in administrative data
Leslie R Harrold, Kenneth G Saag, Robert A Yood, et al.
Respiratory Research
|
April 9, 2024
Targeting transitioning lung monocytes/macrophages as treatment strategies in lung disease related to environmental exposures
Aaron D Schwab, Todd A Wyatt, Grace Moravec, et al.
Annals of the Rheumatic Diseases
|
May 29, 2021
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis
Tate M Johnson, Harlan R Sayles, Joshua F Baker, et al.
Therapeutic Advances in Musculoskeletal Disease
|
November 9, 2023
Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a <i>post hoc</i> analysis of ORAL Surveillance
George A Karpouzas, Zoltán Szekanecz, Eva Baecklund, et al.
ACR Open Rheumatology
|
July 26, 2023
Lowering Expectations: Glucocorticoid Tapering Among Veterans With Rheumatoid Arthritis Achieving Low Disease Activity on Stable Biologic Therapy
Beth I Wallace, Bryant R England, Joshua F Baker, et al.
Page
of 36
Search research articles
Search
Showing results (181-190 of 351) with videos related to
Sort By:
Page
of 36
Clinical and Experimental Rheumatology
|
November 13, 2018
Body mass index and persistence of conventional DMARDs and TNF inhibitors in rheumatoid arthritis
Caroline B McCulley, Jennifer L Barton, Grant W Cannon, et al.
Arthritis Care & Research
|
August 18, 2019
Performance of Administrative Algorithms to Identify Interstitial Lung Disease in Rheumatoid Arthritis
Bryant R England, Punyasha Roul, Tina D Mahajan, et al.
Frontiers in Immunology
|
September 1, 2023
Citrullinated and malondialdehyde-acetaldehyde modified fibrinogen activates macrophages and promotes an aggressive synovial fibroblast phenotype in patients with rheumatoid arthritis
Nozima Aripova, Michael J Duryee, Bryant R England, et al.
Annals of the Rheumatic Diseases
|
December 15, 2015
Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis
Anja Schwenzer, Xia Jiang, Ted R Mikuls, et al.
Frontiers in Immunology
|
April 9, 2020
Heightened Levels of Antimicrobial Response Factors in Patients With Rheumatoid Arthritis
Prathapan Ayyappan, Robert Z Harms, Jennifer A Seifert, et al.
Arthritis and Rheumatism
|
February 3, 2007
Validity of gout diagnoses in administrative data
Leslie R Harrold, Kenneth G Saag, Robert A Yood, et al.
Respiratory Research
|
April 9, 2024
Targeting transitioning lung monocytes/macrophages as treatment strategies in lung disease related to environmental exposures
Aaron D Schwab, Todd A Wyatt, Grace Moravec, et al.
Annals of the Rheumatic Diseases
|
May 29, 2021
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis
Tate M Johnson, Harlan R Sayles, Joshua F Baker, et al.
Therapeutic Advances in Musculoskeletal Disease
|
November 9, 2023
Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a <i>post hoc</i> analysis of ORAL Surveillance
George A Karpouzas, Zoltán Szekanecz, Eva Baecklund, et al.
ACR Open Rheumatology
|
July 26, 2023
Lowering Expectations: Glucocorticoid Tapering Among Veterans With Rheumatoid Arthritis Achieving Low Disease Activity on Stable Biologic Therapy
Beth I Wallace, Bryant R England, Joshua F Baker, et al.
Page
of 36